Our Year in Review: Insights, outcomes, and highlights that shaped 2025. Read the full report!
Aligning Science Across Parkinson's Logo Text

Solid phase binding assay – Clusterin binding to Very Low-Density Lipoprotein Receptor (VLDLR)

Output Details

This protocol details how to monitor Clusterin binding to the Very Low-Density Lipoprotein Receptor (VLDLR) by Enzyme-linked immunosorbent assays (ELISA) adapted from Leeb et al. (2014).
Tags
  • CLU (Clusterin)
  • ELISA
  • Protein aggregates

Meet the Authors

  • Patricia Yuste Checa, PhD

    Key Personnel: Team Harper

    Max Planck Institute of Biochemistry

  • User avatar fallback logo

    Andreas Bracher

    External Collaborator

  • Franz-Ulrich Hartl, MD

    Co-PI (Core Leadership): Team Harper

    Max Planck Institute of Biochemistry

Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.